ISCT Join as Strategic Partners for Phacilitate Trade Mission to Japan and South Korea

Experts from North American and European organisations are also supporting the trade mission. Anthony Davies, Ph.D., CEO of Dark Horse Consulting added, “As the first and only global consulting practice focused on CMC for cell and gene therapy, Dark Horse thoroughly endorses the intent of this trade mission. We also welcome the ISCT’s participation as a strategic partner. I look forward both to presenting our approach to navigating the challenges of manufacturing and regulating ATMPs, but also to listening to the concerns and aspirations of the Pacific Rim’s pioneers and participants in this field.”

We use cookies to help give you the best experience on our website. By continuing you agree to our use of cookies.